Hepion Pharmaceuticals
$1.619876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.05 (-2.98%) Today
-$0.02 (-1.23%) As of 4:00 AM EDT after-hours
Why Robinhood?
You can buy or sell HEPA and other stocks, options, ETFs, and crypto commission-free!
About HEPA
Hepion Pharmaceuticals, Inc. engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. Read More The company was founded on May 15, 2013 and is headquartered in Edison, NJ.
Employees
14
Headquarters
Edison, New Jersey
Founded
2013
Market Cap
10.20M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
34.16K
High Today
$1.68
Low Today
$1.56
Open Price
$1.67
Volume
127.50K
52 Week High
$19.60
52 Week Low
$1.02
Collections
HEPA Earnings
-$7.48
-$4.99
-$2.49
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 13, Pre-Market